Exciting news was presented at ENDO 2015 regarding the use of Denosumab for osteoporosis in post-menopausal women who are at high risk for bone fractures. Results from a comprehensive trial coined Freedom showed the use of Denosumab successfully increased bone mineral density (BMD) at cortical bone sites, particularly the 1/3 radius skeletal site which does[…]
Increased Bone Mineral Density in Denosumab Data Presented at ENDO 2015
Drug Research & Development API, Monoclonal Antibodies / mAb, Osteoporosis Tags: osteoporosisvitamin D Aug 17, 2015
Vitamin D Study Reveals Numerous Health Benefits
Drug Research & Development API Tags: vitamin D Apr 05, 2013
A recent study released from the School of Medicine at Boston University revealed the benefits of Vitamin D are greater than previously thought. The study, coined PLOS ONE, demonstrated there are considerable benefits of vitamin D for healthy adults. We all are aware that when our vitamin D levels are increased our bone health benefits.[…]
Rilpivirine Proves to be a Worthy HIV Opponent
Anti-Retroviral / Anti-HIV, Antiviral, FDA Approved 2011 Tags: EUHIV infectionvitamin D Nov 28, 2012
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor {NTRI} known as the brand name Edurant. Rilpivirine is used to treat HIV-1 infection, and it is often dispensed alongside other antiretroviral agents. As a 25 milligram tablet designed to be taken once daily with food, rilpivirine is effective at decreasing the amount of HIV infection in the[…]
Vitamin D Analogues Clinically Useful for Several Conditions
Anti-Psoriatic, Chemotherapeutic / Anti-Neoplastic, Drug Research & Development API, Hypocalcemia, Osteoporosis Tags: hypocalcemiaosteoporosisplaque psoriasisPsoriasisvitamin D May 02, 2012
Calcium regulation in the human body. The role of vitamin D is shown in orange. There are several active pharmaceutical ingredient products known as vitamin D analogues, which are derivatives of this powerful vitamin, designed to aid patients’ health and well being. Vitamin D is known by many people as the vitamin that helps to[…]
Paricalcitol is Still the Best First Line Treatment for Secondary Hyperparathyroidism (SHPT)
Drug Research & Development API Tags: hypocalcemiavitamin D Aug 08, 2011
Secondary hyperparathyroidism (SHPT) is a common complication associated with chronic renal failure. The damaged kidneys do not convert enough vitamin D to its active form, calciferol, and inadequately excrete phosphate. This results in the formation of insoluble calcium phosphate in the body and removal of calcium from the blood circulation. Both processes lead to hypocalcemia,[…]